Page last updated: 2024-09-05

ml 23 and Idiopathic Parkinson Disease

ml 23 has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kennedy, GA; Willis, GL1
Willis, GL1

Reviews

2 review(s) available for ml 23 and Idiopathic Parkinson Disease

ArticleYear
The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease.
    Reviews in the neurosciences, 2004, Volume: 15, Issue:1

    Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; Humans; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reaction Time; Rotation; Time

2004
The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease.
    Drug news & perspectives, 2005, Volume: 18, Issue:7

    Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Disease Models, Animal; Humans; Levodopa; Melatonin; Parkinson Disease

2005